Krystal Biotech (KRYS) Asset Utilization Ratio (2023 - 2026)

Krystal Biotech has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.3 in Q2 2026.

• Asset Utilization Ratio for Q2 2026 came in at 0.3, down 6.34% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.3 (down 6.34% YoY), and the FY2025 annual result was 0.33, up 5.05% from the prior year.
• Asset Utilization Ratio fell to 0.3 in Q2 2026, from 0.31 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.32 in Q2 2025 and troughed at 0.01 in Q3 2023.
• A 4-year average of 0.23 and a median of 0.29 in 2024 frame the typical range for Asset Utilization Ratio.
• The widest annual swing landed in 2024, when Asset Utilization Ratio soared 2091.09%; it then dropped 6.34% in 2026.
• A 4-year view of Asset Utilization Ratio shows it stood at 0.06 in 2023, then surged by 352.34% to 0.29 in 2024, then climbed by 6.06% to 0.3 in 2025, then increased by 0.56% to 0.3 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.3 in Q2 2026, 0.31 in Q1 2026, and 0.3 in Q4 2025.